Found 1052 matches for
15 October 2014
Dr Anne Kiltie and her team of scientists in the Department of Oncology are trying to give patients with bladder cancer the information they need to choose between radiotherapy and surgery.
8 October 2014
Schools are a vital way of reaching the 10–20% of children and young people across the globe who would benefit from some sort of mental health intervention, says Dr Mina Fazel, a child psychiatrist at the University of Oxford.
3 October 2014
The New Yorker reports on an article by a group of researchers from the Centre for Neural Circuits and Behaviour in the latest issue of the journal Nature Neuroscience. The group, which is led by Scott Waddell, studies rewards, motivation, and memory in the comparatively simple brain of the fruit fly.
2 October 2014
More than one in ten of all antibiotic treatments in the primary care setting are associated with failure, according to research recently published in the BMJ.
30 September 2014
Recent work by Professor Kristijan Ramadan, Associate Professor and MRC Senior Group Leader in the University of Oxford's Department of Oncology, his team Dr. Bruno Vaz, Swagata Halder and Judith Oehler, and colleagues from across the world has discovered a gene which is directly related to both ageing and cancer.
23 September 2014
Department of Biochemistry's Alison Woollard travelled East this Summer to entertain youngsters with her 'Life Fantastic' lectures.
23 September 2014
Potential new treatments for Ebola are to be tested in West Africa for the first time as part of an international initiative to fast-track trials of the most promising drugs against the disease that has already led to over 2,600 deaths.
22 September 2014
Dry roasted peanuts are more likely to trigger an allergy to peanuts than raw peanuts, suggests an Oxford University study involving mice.
18 September 2014
The first healthy UK volunteer has received a candidate Ebola vaccine in Oxford in a safety trial carried out by the University of Oxford.
5 September 2014
The first international standards for fetal growth and newborn size have been developed by a global team led by scientists from Oxford University.
3 September 2014
The size of different brain regions relates to our status in the social hierarchies we encounter every day.
28 August 2014
An unprecedented international consortium, including Oxford, has been assembled to accelerate trials of a candidate Ebola vaccine
28 August 2014
Around three-quarters of cancer patients who have major depression do not currently receive treatment for their depression, new research led by Oxford University has found. But the researchers show that a new treatment programme is strikingly more effective at reducing depression and improving quality of life among cancer patients than current care.
20 August 2014
A group of Oxford researchers has revealed promising new findings about a protein necessary for invasion of red blood cells by malarial parasites.
11 August 2014
As we report the spread of drug-resistant malaria parasites on our news pages – and the scale of the threat this poses to global efforts to control malaria – two other studies published today by Oxford University researchers report promising results in developing new drugs and vaccines against malaria.
7 August 2014
An anti-inflammatory peptide discovered by David Greaves and his group in the Dunn School of Pathology will be tested for its ability to treat psoriasis following a licensing deal between the University of Oxford’s ISIS Innovation and San Francisco start-up Rogne Biosciences.
4 August 2014
Two projects involving Oxford University technology are winners of the 2014 Google Impact Challenge, and will each receive £500,000.
31 July 2014
Resistance to the world's most effective anti-malarial drug, artemisinin, is now widespread across mainland Southeast Asia, seriously threatening global malaria control and elimination, according to a study led by Oxford University researchers based in Thailand.
29 July 2014
Oxford University scientists have shown that a drug given at the time of a kidney transplant operation halves the risk of early rejection of the organ. The drug, called alemtuzumab, also allows a less toxic regimen of anti-rejection drugs to be used after the operation.
28 July 2014
The parts of the world that would benefit most from research on the biggest health problems – like malaria, HIV, maternal health problems and diarrhoea – are also the regions where that research is most lacking.